Pfizer press release: concerns over Cov Sars 2 vaccine safety and efficacy - On Line Opinion
What many have known is now official.
Source: onlineopinion.com.au
Stay updated with breaking news from Pfizer Responds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
What many have known is now official.
Pfizer-BioNTech seeks an FDA emergency use approval in the US for children aged 5-11. This booster dose is intended for the original Covid strain, Omicron, and BA.4 and BA.5 subvariants.